Skip to content

Towards an expanded neurocognitive account of ketamine's rapid antidepressant effects.

Yingliang Dai, Ben J Harrison, Christopher G Davey, Trevor Steward

The international journal of neuropsychopharmacology February 4, 2025 DOI: 10.1093/ijnp/pyaf010 via PubMed

Summary

AI-generated from the abstract

Ketamine, a fast-acting antidepressant, works by blocking N-methyl-D-aspartate receptors. While its molecular mechanisms are known, its large-scale neurocognitive effects are less clear. This synthesis links ketamine treatment to changes in brain systems for reward processing, interoception, and self-related cognition. The authors suggest that ketamine's antidepressant effects arise from dynamic, multi-level influences across these functional domains.

Study at a glance

Characteristics Review Peer reviewed
Intervention Ketamine
Topics Depression Ketamine
Keywords Neurocognitive Depression/mental-health/mood-disorders Ketamine/psychopharmacology/antidepressants Neuroscience/neurobiology/brain-research
Citations 6
Key finding Ketamine's antidepressant effects are driven by modulation of brain systems supporting reward processing, interoception, and self-related cognition.

Abstract

Ketamine is an N-methyl-D-aspartate receptor antagonist that has shown effectiveness as a rapidly acting treatment for depression. Although advances have been made in understanding ketamine's antidepressant pharmacological and molecular mechanisms of action, the large-scale neurocognitive mechanisms driving its therapeutic effects are less clearly understood. To help provide such a framework, we provide a synthesis of current evidence linking ketamine treatment to the modulation of brain systems supporting reward processing, interoception, and self-related cognition. We suggest that ketamine's antidepressant effects are, at least in part, driven by dynamic multi-level influences across these key functional domains.

Explore topics

Comments

No comments yet.

Log in to comment